Retrophin

RTRX NASDAQ
20.15
-0.28
-1.37%
交易中 14:06 06/24 EDT
开盘
20.50
昨收
20.43
最高
20.58
最低
20.15
成交量
32.90万
成交均量(3M)
38.93万
52周最高
33.00
52周最低
17.53
换手率
0.79%
市值
8.35亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Retrophin RTRX股票价格,Retrophin股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Retrophin, Inc. is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The Company sells three products, including Chenodal (chenodeoxycholic acid), Cholbam (cholic acid) and Thiola (tiopronin). Its Chenodal is approved in the United States for the treatment of patients suffering from gallstones in whom surgery poses an unacceptable health risk due to disease or advanced age. Chenodal has also been care for cerebrotendinous xanthomatosis (CTX) patients. Its Cholbam is approved in the United States for the treatment of bile acid synthesis disorders due to single enzyme defects and is further indicated for adjunctive treatment of patients with peroxisomal disorders. Its Thiola is approved in the United States for the prevention of cystine (kidney) stone formation in patients with severe homozygous cystinuria.
展开 >

最近浏览

名称
价格
涨跌幅